Descending serotonergic bulbospinal pain pathway

The descending serotonergic bulbospinal pain pathway is a critical component of the endogenous pain modulation system that originates in the rostral ventromedial medulla (RVM), particularly the nucleus raphe magnus (StatPearls, 2023). These neurons project to the dorsal horn of the spinal cord, where they release serotonin (5-HT) to regulate the transmission of nociceptive information (PubMed, PMC3439544). Depending on the specific 5-HT receptor subtypes activated—such as 5-HT1A/B for inhibition versus 5-HT3 for facilitation—this pathway can either suppress or enhance pain signals (Journal of Neuroscience, 2019). Dysregulation of this system is strongly implicated in the development and maintenance of chronic and neuropathic pain states, often characterized by a loss of inhibitory control or an increase in descending facilitation (NIH, 2022). Pharmacological interventions, such as serotonin-norepinephrine reuptake inhibitors (SNRIs) and tricyclic antidepressants, target this pathway by increasing the availability of serotonin in the spinal cord to reinforce descending inhibition (PubChem, 2024).

Other names

Descending serotonergic systemBulbospinal serotonergic pathwayDescending inhibitory pain pathwayRVM-spinal serotonergic projection

Enhancement of synaptic serotonin levels in the spinal cord dorsal horn, which activates various 5-HT receptor subtypes to modulate (primarily inhibit) the transmission of nociceptive signals from primary afferents to second-order neurons.